Evidence map›Paper›PMID 35344398›Full record

ReviewJCO oncology practice2022

The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator.

Andrea Anampa-Guzmán, Janet Freeman-Daily, Michael Fisch, Emil Lou, Nathan A Pennell, Corrie A Painter, Dorinda Sparacio, Mark A Lewis, Maimah Karmo, Patricia F Anderson and 2 more

Abstract readReview
In one paragraph

Review in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cancer misinformation on social media.CA: a cancer journal for clinicians
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea Anampa-GuzmánSan Fernando Medical School, Faculty of Medicine, Universidad Nacional Mayor de San Marcos. Lima, Peru.ORCID 0000-0002-4292-1137
Janet Freeman-DailyThe ROS1ders Inc, Sacramento, CA.ORCID 0000-0003-3702-7912
Michael FischDepartment of General Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-5312-403X
Emil LouMasonic Cancer Center, Minneapolis, MN.ORCID 0000-0002-1607-1386
Nathan A PennellCleveland Clinic Taussig Cancer Institute, Cleveland, OH.ORCID 0000-0002-1458-0064
Corrie A PainterBroad Institute of MIT and Harvard University, Cambridge, MA.
Dorinda Sparacio#gyncsm Twitter Community, Hightstown, NJ.
Mark A LewisIntermountain Healthcare, Murray, UT.ORCID 0000-0001-8633-6557
Maimah KarmoTigerlily Foundation, Reston, VA.ORCID 0000-0002-5500-977X
Patricia F AndersonVirtual Projects Advisory Committee, and Emerging Technologies Informationist, Taubman Health Sciences Library, University of Michigan, Ann Arbor, MI.ORCID 0000-0001-6348-2324
Stephanie L GraffDepartment of Medicine, Warren Alpert Medical School of Brown University, Providence, RI.ORCID 0000-0003-1928-1722
Collaboration for Outcomes using Social Media in Oncology

Funding

The Collaboration for Outcomes using Social Media in Oncology (COSMO) ConferenceR13CA239613 · NCI · RHODE ISLAND HOSPITAL · PI DIZON, DON S · 2020 to 2020
$10k
NCI NIH HHS R13 CA239613
6 · The paper itself

Abstract

purposePatients who have cancer have leveraged the Internet to gain a better understanding of their disease and connect across geographic boundaries with others facing the same challenges. Online cancer communities have developed into resources that highlight new research and evolving care pathways. Combined with increasing health literacy and social media, they have enabled some patients to become experts in their cancer. This combination of empowerment and expertise describes the new "e-patients."

methodsWe reviewed the literature to identify key areas where expert e-patients have directly participated in advancing cancer medicine, as well as opportunities available to those who wish to become more involved in research advocacy.

resultsE-patients are widely acknowledged as key stakeholders in oncology by clinicians, researchers, cancer centers, government agencies, and nonprofits. Their input is vital for informing cancer care delivery, developing and launching research initiatives, creating care guidelines and pathways, and formulating policy.

conclusionExpert e-patients play an expanded role in their own care and in larger conversations regarding practice, research, and policy. Clinicians can engage e-patients as partners in cancer care as we work together towards improving health care access and outcomes for people with cancer.

Indexed as

NeoplasmsCommunicationHealth Services AccessibilityHumansMedical Oncology

Identifiers

PMID35344398
PMCPMC9377686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.